MedTrace Logo

A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation

NCT06660069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2026-03-18

Study results available
· View outcomes & findings →

Summary

The aim of this study is to assess the ability of a marketed Cetylpyridinium Chloride (CPC) mouthwash alongside a marketed Stannous Fluoride (SnF2) toothpaste in improving gingival health and reducing plaque accumulation, compared to the use of a regular fluoride toothpaste alone in participants with clinically measurable plaque-induced gingivitis.

Conditions

  • Dental Plaque
  • Gingivitis

Interventions

DRUG

Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)

Toothpaste containing 0.454 percent (%) weight by weight (w/w) SnF2.

DRUG

CPC Mouthwash (Parodontax Active Gum Health Mouthwash)

Mouthwash containing 0.07% w/w CPC.

DRUG

Regular Fluoride Toothpaste (Crest Cavity Protection)

Toothpaste containing 0.243% w/w sodium fluoride.

DRUG

Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)

Toothpaste containing 0.454% w/w SnF2.

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2025-03-11
Completion
2025-03-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06660069 on ClinicalTrials.gov